How to Validate a DNMT1 Knockout Clone

Validate in this order, and do not skip step 3: junction sequencing and zygosity → protein absence → global 5mC → locus-specific methylation → passage-matched comparison. A DNMT1 knockout is only functionally a knockout once methylation has had enough divisions to decay, so a clone validated at passage 3 may look almost wild-type.

• • Sequence both junctions (5′ and 3′) and confirm the edit removes an essential exon or creates a frameshift early in the coding sequence.
• • Determine zygosity by digital PCR or by quantitative junction analysis. A heterozygous clone will behave like a hypomorph and is the most common source of confusing methylation data.
• • For compound knockouts, confirm each allele of each gene separately — a "double knockout" is often a double heterozygote.

• • Western blot with an antibody validated against a knockout or knockdown control. DNMT1 is large; check for truncated species that could retain partial function.
• • Quantify relative to a loading control across passages; residual protein that declines with passage suggests selection for escapes rather than a clean null.
• • mRNA absence alone is not sufficient: feedback and alternative transcripts can produce detectable protein.

This is the step that decides interpretation.

• • Method. LUMA, HPLC, or a validated global 5mC assay; report in absolute terms where possible.
• • Timing. Methylation decays roughly with divisions. Sample at early and late passages and plot the trajectory rather than reporting a single value.
• • Expectation. A substantial global reduction is expected for a true maintenance defect — but the magnitude depends on the starting methylome, the proliferation rate, and whether other DNMTs compensate at some loci.

A clone with unchanged global methylation at passage 15 is either not a knockout, or the line has a compensating mechanism worth reporting.

Global assays miss locus heterogeneity. Measure:

• • A region expected to lose methylation (repeats, heterochromatin, known DNMT1-dependent loci).
• • A control region expected to be relatively stable.
• • Your locus of interest, if the clone exists to study it.

Report per-CpG values with coverage, not just regional means. Locus-specific data are what make the clone usable for a specific project.

Compare edited clones to parental cells at matched passages, since parental methylation also drifts in culture. A comparison to a passage-3 parental stock against a passage-15 knockout confounds genotype with culture time.

Also report proliferation: DNMT1 loss often slows growth, and slower growth itself changes the rate of methylation change.

EDITGENE delivers DNMT1 knockouts with junction sequencing, zygosity by digital PCR, protein-absence confirmation, LUMA-based global methylation at two passages, locus-specific bisulfite data, and passage-matched parental controls.

Tell us the locus you intend to study. Contact EDITGENE to request a project consultation or quote.

Methylation loss after DNMT1 inactivation depends on division number, starting methylome, and compensatory mechanisms; single-timepoint comparisons can misrepresent the phenotype.

A knockout used as a study background should be validated at genotype, protein, and mark level, with passage and growth data reported.

• • Li E, et al. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell. 1992;69:915–926.
• • Rhee I, et al. CpG methylation is maintained in human cancer cells lacking DNMT1. Nature. 2000;404:1003–1007.
• • Karagiannis P, et al. Assessing DNA methylation levels in animals: choosing the right tool for the job. Animal Reproduction. 2015;12:1–9.